Accessibility Menu
International Flavors & Fragrances Stock Quote

International Flavors & Fragrances (NYSE: IFF)

$65.10
(0.4%)
+0.28
Price as of October 23, 2025, 10:48 a.m. ET

KEY DATA POINTS

Current Price
$65.1
Daily Change
(0.4%) +$0.28
Day's Range
$64.94 - $65.77
Previous Close
$64.82
Open
$64.97
Beta
0.88
Volume
217,820
Average Volume
2,254,104
Sector
Market Cap
16.6B
Market Cap / Employee
$64.82M
52wk Range
$59.14 - $104.69
Revenue
-
Gross Margin
0.31%
Dividend Yield
2.47%
EPS
-$1.55
CAPs Rating
-
Industry
Chemicals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

International Flavors & Fragrances Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
IFF-36.23%-32.92%-7.67%+4,284%
S&P+14.5%+93.32%+14.09%+6,871%

International Flavors & Fragrances Company Info

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$2.76B-4.3%
Gross Profit$885.00M-3.3%
Gross Margin32.02%0.3%
Market Cap$18.81B-22.6%
Market Cap / Employee$0.84M0.0%
Employees22.4K4.2%
Net Income$612.00M255.8%
EBITDA$498.00M-14.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$816.00M21.6%
Accounts Receivable$1.80B1.5%
Inventory2.4K9.8%

Liabilities

Q2 2025YOY Change
Long Term Debt$6.26B-32.1%
Short Term Debt$595.00M-31.6%

Ratios

Q2 2025YOY Change
Return On Assets-1.41%5.9%
Return On Invested Capital-2.31%-0.6%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$146.00M-5.8%
Operating Free Cash Flow$241.00M1.7%

Valuation

MetricQ4 2024YoY Change
Price to Earnings89.16-
Price to Book1.881.461.431.43-16.10%
Price to Sales2.361.881.741.67-22.39%
Price to Tangible Book Value-14.05-16.09-12.03-15.22173.10%
Price to Free Cash Flow TTM87.84245.96124.18125.1837.13%
Enterprise Value to EBITDA63.7860.2250.9650.14-13.29%
Free Cash Flow Yield1.1%0.4%0.8%0.8%-27.08%
Return on Equity-14.6%1.7%-6.1%-2.7%-81.41%
Total Debt$9.79B$9.62B$9.91B$6.85B-32.08%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.